Loading chat...
FL H1335
Bill
Status
Failed
6/16/2025
Primary Sponsor
Health Care Facilities & Systems Subcommittee
Click for details
AI Summary
- Requires the Agency for Health Care Administration to establish a provider reimbursement schedule and billing codes for Proprietary Laboratory Analyses codes covering biomarker testing by August 1, 2025
- Authorizes Medicaid to pay for medically necessary blood-based biomarker tests for colorectal cancer screening, expanding beyond the existing prohibition on coverage of biomarker testing for screening purposes
- Requires Medicaid managed care plans to cover blood-based biomarker tests for colorectal cancer screening at the same scope and frequency as other medically necessary colorectal cancer tests and screenings
- Directs the agency to contract for an independent, actuarially sound 5-year cost-benefit analysis of blood-based biomarker tests for colorectal cancer in Medicaid, with an interim report due November 30, 2028, and a final report due November 30, 2030, to the Governor and legislative leaders
- Provisions authorizing colorectal cancer biomarker test coverage and managed care plan requirements are subject to a sunset repeal on July 1, 2031, unless reenacted by the Legislature
Legislative Description
Biomarker Testing
Last Action
Died in Health & Human Services Committee, companion bill(s) passed, see SB 2514 (Ch. 2025-204)
6/16/2025
Committee Referrals
Health And Human Services4/8/2025
Budget Committee3/31/2025
Health Care Facilities & Systems Subcommittee3/5/2025
Full Bill Text
No bill text available